7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The efficacy of tocilizumab for the treatment of Chinese Takayasu's arteritis.

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The aim of this study was to evaluate the efficacy and safety of tocilizumab (TCZ) in Chinese Takayasu's arteritis (TAK) patients.

          Related collections

          Author and article information

          Journal
          Clin. Exp. Rheumatol.
          Clinical and experimental rheumatology
          0392-856X
          0392-856X
          April 14 2017
          : 35 Suppl 103
          : 1
          Affiliations
          [1 ] Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
          [2 ] Department of Rheumatology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
          [3 ] Department of Rheumatology and Nephrology, Minzu Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
          [4 ] Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China. tianxp6@126.com.
          [5 ] Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China. xiaofeng_zeng@cstar.org.
          Article
          11262
          28406764
          32e32e1c-262b-4586-bdc2-ef276f76d9a0
          History

          Comments

          Comment on this article